Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men. (Q51304267)
Jump to navigation
Jump to search
scientific article published in June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men. |
scientific article published in June 2015 |
Statements
Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men. (English)
1 reference
Prasarn Manitpisitkul
1 reference
Arthur Mayorga
1 reference
Kevin Shalayda
1 reference
Marc De Meulder
1 reference
Gary Romano
1 reference
Chen Jun
1 reference
John A Moyer
1 reference
1 June 2015
1 reference
35
1 reference
6
1 reference
353-363
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference